title: Comparison of disodium cromoglycate, terbutaline and thiazinamium in the prevention of exercise-induced asthma and its relation to non-specific bronchial responsiveness.
abstract: The protective effect of pre-exercise treatment with disodium cromoglycate (DC), terbutaline sulphate (TS) and thiazinamium methylsulphate (TM) on exercise-induced asthma (EIA) was investigated. Thirty-one adults each exercised for over 6 min on a bicycle ergometer. Each subject performed five tests. The first and last exercise tests served as controls. A profile of bronchial reactivity based on the combination of hyperreactivity - as measured by acetylcholine (a), histamine (h) and propranolol (p) - was drawn up. The following combinations and frequencies were based on the response (+ or -) in hyperreactivity studies: group (h+, a+, p+) was present in 21 of the 31 patients studied, group (h-, a+, p+) in 6 patients, group (h+, a+, p-) in 2 patients and group (h-, a+, p-) in 2 patients. The proportion of patients effectively protected from their EIA was 80% for TS, 60% for DC and 40% for TM. These findings suggest that there exists a consistent heterogeneity in the patients' response to exercise, possibly related to the individual distribution of receptors leading to bronchial hyperreactivity.
authors.forename: F
authors.initials: F
authors.lastname: Gimeno
authors.forename: R
authors.initials: R
authors.lastname: van Veenen
authors.forename: E J
authors.initials: EJ
authors.lastname: Steenhuis
authors.forename: W C
authors.initials: WC
authors.lastname: Berg
mesh_terms: D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000517:prevention & control*; D001250:Asthma, Exercise-Induced / Q000150:complications / Q000517:prevention & control*; D001982:Bronchial Diseases / Q000503:physiopathology*; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000150:complications; D008297:Male; D008875:Middle Aged; D011398:Promethazine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D012130:Respiratory Hypersensitivity / Q000503:physiopathology*; D013726:Terbutaline / Q000627:therapeutic use*
chemical_list: D011398:Promethazine; D013726:Terbutaline; D004205:Cromolyn Sodium